Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colaci

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The British Journal of Dermatology|August 7, 2012
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblastsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|July 8, 2014
[CXCR3 and CXCL10 in autoimmune thyroiditis]I Ruffilli, S M Ferrari, M Colaci, et al.
Clinical and Experimental Rheumatology|June 21, 2008
Cardiovascular risk and prostanoids in systemic sclerosisM Colaci, M Sebastiani, D Giuggioli, et al.
Scandinavian Journal of Rheumatology|July 5, 2011
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controlsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|September 19, 2013
HCV-related autoimmune disorders in HCV chronic infectionS M Ferrari, P Fallahi, C Mancusi, et al.
Clinical Rheumatology|October 13, 2011
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literatureC U Manzini, M Sebastiani, D Giuggioli, et al.
Clinical Rheumatology|October 17, 2014
Nailfold capillaroscopic changes in dermatomyositis and polymyositisA Manfredi, M Sebastiani, G Cassone, et al.
Reumatismo|May 25, 2016
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baselineM Colaci, D Giuggioli, M Sebastiani, et al.
Scandinavian Journal of Rheumatology|January 12, 2010
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitisM Colaci, M Sebastiani, D Giuggioli, et al.
Occupational Medicine (Oxford, England)|October 4, 2016
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemiaE Artoni, G L Sighinolfi, A M Gatti, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The British Journal of Dermatology|August 7, 2012
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblastsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|July 8, 2014
[CXCR3 and CXCL10 in autoimmune thyroiditis]I Ruffilli, S M Ferrari, M Colaci, et al.
Clinical and Experimental Rheumatology|June 21, 2008
Cardiovascular risk and prostanoids in systemic sclerosisM Colaci, M Sebastiani, D Giuggioli, et al.
Scandinavian Journal of Rheumatology|July 5, 2011
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controlsA Antonelli, C Ferri, S M Ferrari, et al.
La Clinica Terapeutica|September 19, 2013
HCV-related autoimmune disorders in HCV chronic infectionS M Ferrari, P Fallahi, C Mancusi, et al.
Clinical Rheumatology|October 13, 2011
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literatureC U Manzini, M Sebastiani, D Giuggioli, et al.
Clinical Rheumatology|October 17, 2014
Nailfold capillaroscopic changes in dermatomyositis and polymyositisA Manfredi, M Sebastiani, G Cassone, et al.
Reumatismo|May 25, 2016
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baselineM Colaci, D Giuggioli, M Sebastiani, et al.
Scandinavian Journal of Rheumatology|January 12, 2010
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitisM Colaci, M Sebastiani, D Giuggioli, et al.
Occupational Medicine (Oxford, England)|October 4, 2016
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemiaE Artoni, G L Sighinolfi, A M Gatti, et al.
Pageof 4